Approval · Notice of Compliance 2180 · 2004
CEFTIN: Notice of Compliance 2180
Issued May 3, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2180
- Date
- May 3, 2004
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation: the addition of 3 new excipients to improve the taste
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFTIN | Not yet assigned | — |
Medicinal ingredients
- CEFUROXIME AXETIL 125 MG per 5ML